What Is Fatty Liver Disease?

What Is Fatty Liver Disease?ByAnnie KayUpdated on April 20, 2024Medically reviewed byRobert Burakoff, MDFatty liver is also known as hepatic steatosis. It happens when fat buil

Updated on: July 01,2024 0

What Is Fatty Liver Disease?

What Is Fatty Liver Disease?ByAnnie KayUpdated on April 20, 2024Medically reviewed byRobert Burakoff, MDFatty liver is also known as hepatic steatosis. It happens when fat buil

Updated on:July 01,2024 0

How protein protects against fatty liver

by Deutsches Zentrum fuer Diabetesforschung DZDMicroscopic images of liver biopsies of three individuals with different degrees of liver fat accumulation. Credit: DIfENon-alcoholic fatty liver disease

Updated on: June 28,2024 3

How protein protects against fatty liver

by Deutsches Zentrum fuer Diabetesforschung DZDMicroscopic images of liver biopsies of three individuals with different degrees of liver fat accumulation. Credit: DIfENon-alcoholic fatty liver disease

Updated on:June 28,2024 3

When Do Liver Cysts Cause Complications?

When Do Liver Cysts Cause Complications?ByAnna GiorgiPublished on July 06, 2023Medically reviewed byRobert Burakoff, MDLiver cysts, also called hepatic cysts, are fluid-filled

Updated on: July 01,2024 0

When Do Liver Cysts Cause Complications?

When Do Liver Cysts Cause Complications?ByAnna GiorgiPublished on July 06, 2023Medically reviewed byRobert Burakoff, MDLiver cysts, also called hepatic cysts, are fluid-filled

Updated on:July 01,2024 0

Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model

by Sichuan International Medical Exchange and Promotion AssociationPrevalence of minimal hepatic encephalopathy (MHE) in different groups of patients with cirrhosis. Credit:MedComm(2024).

Updated on: August 01,2024 0

Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model

by Sichuan International Medical Exchange and Promotion AssociationPrevalence of minimal hepatic encephalopathy (MHE) in different groups of patients with cirrhosis. Credit:MedComm(2024).

Updated on:August 01,2024 0

Research supports TCM liver-breast cancer theory: Fatty liver linked to deteriorating breast cancer

byThe University of Hong KongA) Trial schematic for establishing an HFD-fed NAFLD-breast cancer mice model. B, C) Mice on the HFD diet showed accelerated body weight growth (B) and higher body f

Updated on: July 11,2024 0

Research supports TCM liver-breast cancer theory: Fatty liver linked to deteriorating breast cancer

byThe University of Hong KongA) Trial schematic for establishing an HFD-fed NAFLD-breast cancer mice model. B, C) Mice on the HFD diet showed accelerated body weight growth (B) and higher body f

Updated on:July 11,2024 0

What a MELD Score Means

What a MELD Score MeansByLynne Eldridge, MDUpdated on June 05, 2023Medically reviewed byJay N. Yepuri, MDA MELD score, short for Model for End-Stage Liver Disease, can provide

Updated on: July 01,2024 0

What a MELD Score Means

What a MELD Score MeansByLynne Eldridge, MDUpdated on June 05, 2023Medically reviewed byJay N. Yepuri, MDA MELD score, short for Model for End-Stage Liver Disease, can provide

Updated on:July 01,2024 0

Proof-of-concept study demonstrates novel strategy to develop liver-targeting chimeras for disease treatment

by Liu Jia,Chinese Academy of SciencesCredit:Journal of Controlled Release(2024). DOI: 10.1016/j.jconrel.2024.08.044Liver cancer ranks as the fourth most common cancer and the second

Updated on: September 15,2024 0

Proof-of-concept study demonstrates novel strategy to develop liver-targeting chimeras for disease treatment

by Liu Jia,Chinese Academy of SciencesCredit:Journal of Controlled Release(2024). DOI: 10.1016/j.jconrel.2024.08.044Liver cancer ranks as the fourth most common cancer and the second

Updated on:September 15,2024 0

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on: September 21,2024 0

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on:September 21,2024 0

When Lung Cancer Spreads to the Liver

When Lung Cancer Spreads to the LiverSymptoms, Treatments, and PrognosisByLynne Eldridge, MDUpdated on August 11, 2022Medically reviewed byGagandeep Brar, MDLung cancer spread

Updated on: July 01,2024 0

When Lung Cancer Spreads to the Liver

When Lung Cancer Spreads to the LiverSymptoms, Treatments, and PrognosisByLynne Eldridge, MDUpdated on August 11, 2022Medically reviewed byGagandeep Brar, MDLung cancer spread

Updated on:July 01,2024 0

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on: June 28,2024 5

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Updated on:June 28,2024 5

Bacteria in the bile duct may provide a new clue for treating liver disease

by ElsevierRepresentative flow plots showing CD69+ granzyme B+(GrB+) activated mucosal-associated invariant T (MAIT) cells within peripheral blood mononuclear cells (PBMCs) after incubation with

Updated on: June 28,2024 4

Bacteria in the bile duct may provide a new clue for treating liver disease

by ElsevierRepresentative flow plots showing CD69+ granzyme B+(GrB+) activated mucosal-associated invariant T (MAIT) cells within peripheral blood mononuclear cells (PBMCs) after incubation with

Updated on:June 28,2024 4

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on: September 10,2024 0

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on:September 10,2024 0